Decipher Bladder

About Decipher Biosciences

Decipher Biosciences is a commercial-stage molecular diagnostics company specializing in genomic classifiers for urologic cancers. Its flagship products, the Decipher Prostate and Decipher Bladder tests, analyze gene expression from tumor tissue to stratify patient risk and inform treatment decisions, such as the choice between active surveillance or aggressive intervention. The company, founded in 2017 and based in San Diego, is now a key urology franchise within the publicly traded diagnostics leader Veracyte. Its tests are supported by extensive clinical validation and are integrated into major clinical guidelines, positioning it as a leader in the precision oncology diagnostics space for prostate cancer.

Therapeutic Areas

Other Bladder Cancer Drugs